Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Lv Ray
    Member
    • Jun 2014
    • 42

    #1

    Use bowtie2 to analysis DNA-reseq data

    Hi dear,
    I am going to deal with my big DNA-reseq data by bowtie2! I have finished index buliding , now I am preparing for mapping. But there're so many arguments to adjust! can I just use all the default ? but it seems not good.
    Can anybody tell me a complete solution or a paper about bowtie2-mapping pipeline? please Add your detail reasons for every argument, that is best!
  • gringer
    David Eccles (gringer)
    • May 2011
    • 845

    #2
    Use the default options initially, because it's reasonable to assume that the people who wrote the program have a good idea about the behaviour of their program, and have set up the defaul options to work the best in a general situation. You're going to be splitting hairs (and racking up bioinformatics time) by playing around with bowtie options, so save that for when the reviewers of your Nature paper get back to you.

    Comment

    • Lv Ray
      Member
      • Jun 2014
      • 42

      #3
      gringer, thanks for your answer ! I will use the default options to try my data. However, I don't agree your second point that the default options is the best. Becuase I think they set so many options in order to adapt other situations.

      Comment

      • gringer
        David Eccles (gringer)
        • May 2011
        • 845

        #4
        Not the best in all situations, but they should be the best in most situations. To say that is not the case is implicitly saying that you understand the program better than the people who wrote it, which is a dangerous path to travel down.

        If you're interested in differential expression and fold-change differences of 1.1x, then fiddling with the options will probably have a big impact on your results. However if you're only fishing for the most obvious differences (i.e. "statistically significant"), and fold changes of 2x or more, then a few more reads here and there shouldn't affect the outcome of your analysis (and if it does, you probably shouldn't trust your answer).

        Comment

        • Lv Ray
          Member
          • Jun 2014
          • 42

          #5
          Thank you very much.

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
            by SEQadmin2



            CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

            Despite this, “CRISPR helped turn genome editing from a specialized technique into
            ...
            07-31-2026, 11:01 AM
          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            07-20-2026, 11:48 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, Today, 07:41 AM
          0 responses
          9 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 08-03-2026, 10:13 AM
          0 responses
          25 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-31-2026, 02:55 AM
          0 responses
          38 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-24-2026, 12:17 PM
          0 responses
          25 views
          0 reactions
          Last Post SEQadmin2  
          Working...